SCIENCE@home

A Role for von Hippel-Lindau Protein in Pancreatic β-Cell Function

Sapna Puri,D. Cano,Matthias Hebrok

Published 2009 in Diabetes

ABSTRACT

OBJECTIVE—The Vhlh gene codes for the von Hippel-Lindau protein (VHL), a tumor suppressor that is a key player in the cellular response to oxygen sensing. In humans, a germline mutation in the VHL gene leads to the von Hippel-Lindau disease, a familial syndrome characterized by benign and malignant tumors of the kidney, central nervous system, and pancreas. RESEARCH DESIGN AND METHODS—We use Cre-lox recombination to eliminate Vhlh in adult mouse pancreatic β-cells. Morphology of mutant islets is assessed by immunofluorescence analysis. To determine the functional state of Vhlh−/− islets, insulin secretion is measured in vivo and in vitro, and quantitative PCR is used to identify changes in gene expression. RESULTS—Loss of VHL in β-cells leads to a severe glucose-intolerant phenotype in adult animals. Although VHL is not required for β-cell specification and development, it is critical for β-cell function. Insulin production is normal in β-cells lacking VHL; however, insulin secretion in the presence of high concentrations of glucose is impaired. Furthermore, the loss of VHL leads to dysregulation of glycolytic enzymes, pointing to a perturbation of the intracellular energy homeostasis. CONCLUSIONS—We show that loss of VHL in β-cells leads to defects in glucose homeostasis, indicating an important and previously unappreciated role for VHL in β-cell function. We believe that the β-cell–specific Vhlh-deficient mice might be a useful tool as a “genetic hypoxia” model, to unravel the possible link between hypoxia signaling and impairment of β-cell function.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-54 of 54 references · Page 1 of 1

CITED BY

Showing 1-100 of 106 citing papers · Page 1 of 2

12
Next